The subsequent release of growth factors and calcium into the bone microenvironment stimulates additional proliferation of tumor cells and release of tumor-derived factors, and thus further increases the RANKL/OPG ratio, thereby promoting continued RANKL-dependent osteoclast-mediated bone destruction [18]. The gene discussed is TNFSF11; the disease is neoplasm.